Phase I dose escalation studies in pediatric cancer patientsAOST0221: Phase II study of inhaled GM-CSF in first pulmonary recurrence of osteosarcoma patientsPhase II study of GM-CSF in combination with chemotherapy and radiation in EWS patients. The gene discussed is CSF2; the disease is osteosarcoma.